CIK 0001053369 · Non-accelerated filer<br>Smaller reporting company
ELITE PHARMACEUTICALS INC /NV/
Sign in to watch- Ticker
- ELTP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 223542636
- Phone
- 2017502646
- Business address
- 165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
- Former names
- ELITE PHARMACEUTICALS INC /DE/
- Open-market buys, last 90 days
- $34,590
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$34,590. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-11-19 | NIGALAYE ASHOK G Chief Scientific Officer | Sale | −21,000 | $0.12 | $2K | 21,547,348 |
| 2013-11-19 | EPIC PHARMA LLC 10% owner | Sale | −21,000 | $0.12 | $2K | 71,824,493 |
| 2013-11-19 | EPIC INVESTMENTS, LLC 10% owner | Sale | −21,000 | $0.12 | $2K | 71,824,493 |
| 2013-11-18 | NARINE JEENARINE Director | Sale | −1,170,000 | $0.12 | $137K | 15,806,008 |
| 2013-11-18 | NIGALAYE ASHOK G Chief Scientific Officer | Sale | −1,170,000 | $0.12 | $137K | 21,553,648 |
| 2013-11-18 | EPIC PHARMA LLC 10% owner | Sale | −1,170,000 | $0.12 | $137K | 71,845,493 |
| 2013-11-18 | EPIC INVESTMENTS, LLC 10% owner | Sale | −1,170,000 | $0.12 | $137K | 71,845,493 |
| 2013-11-15 | EPIC PHARMA LLC 10% owner | Sale | −253,050 | $0.12 | $30K | 72,950,493 |
| 2013-11-15 | EPIC INVESTMENTS, LLC 10% owner | Sale | −253,050 | $0.12 | $30K | 72,950,493 |
| 2013-11-15 | NARINE JEENARINE Director | Sale | −253,050 | $0.12 | $30K | 16,049,109 |
| 2013-11-15 | NIGALAYE ASHOK G Chief Scientific Officer | Sale | −253,050 | $0.12 | $30K | 21,885,148 |
| 2013-11-15 | EPIC PHARMA LLC 10% owner | Sale | +253,050 | $0.12 | $30K | 72,950,493 |
| 2013-11-15 | EPIC INVESTMENTS, LLC 10% owner | Sale | +253,050 | $0.12 | $30K | 72,950,493 |
| 2013-11-15 | NARINE JEENARINE Director | Sale | −318,050 | $0.12 | $37K | 16,063,408 |
| 2013-11-15 | NIGALAYE ASHOK G Chief Scientific Officer | Sale | −318,050 | $0.12 | $37K | 24,095,113 |
| 2013-11-15 | EPIC PHARMA LLC 10% owner | Sale | −318,050 | $0.12 | $37K | 73,015,493 |
| 2013-11-15 | EPIC INVESTMENTS, LLC 10% owner | Sale | −318,050 | $0.12 | $37K | 73,015,493 |
| 2013-11-14 | NARINE JEENARINE Director | Sale | −465,090 | $0.12 | $54K | 16,133,379 |
| 2013-11-14 | NIGALAYE ASHOK G Chief Scientific Officer | Sale | −465,090 | $0.12 | $54K | 24,200,069 |
| 2013-11-14 | EPIC PHARMA LLC 10% owner | Sale | −465,090 | $0.12 | $54K | 73,333,543 |
Page 12 of 18 · 356 trades